10th Anniversary of Biomedicines—Biomarkers in Pain
Pain biomarkers are biological indicators or measurable characteristics that can provide information about the presence, severity, or underlying mechanisms of pain. They are valuable for several reasons: Diagnosis and differential diagnosis: Biomarkers can help in the diagnosis of various pain condi...
שמור ב:
| פורמט: | Online |
|---|---|
| שפה: | אנגלית |
| יצא לאור: |
MDPI - Multidisciplinary Digital Publishing Institute
2024
|
| נושאים: | |
| גישה מקוונת: | ONIX_20240108_9783036597928_104 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
| _version_ | 1869526600165359616 |
|---|---|
| collection | Directory of Open Access Books |
| description | Pain biomarkers are biological indicators or measurable characteristics that can provide information about the presence, severity, or underlying mechanisms of pain. They are valuable for several reasons: Diagnosis and differential diagnosis: Biomarkers can help in the diagnosis of various pain conditions and differentiate between different types of pain, such as neuropathic, inflammatory, or nociceptive pain. This can lead to more accurate and timely diagnoses, which in turn can improve patient care. Monitoring treatment efficacy: Pain biomarkers can be used to track how well treatments are working for individuals suffering from chronic pain conditions. This allows healthcare providers to make informed decisions about adjusting treatment plans, optimizing pain management, and avoiding unnecessary or ineffective interventions. Drug development and testing: Biomarkers play a crucial role in the development of new pain medications and therapies. They can help researchers identify potential drug targets, screen compounds for their pain-relieving properties, and assess the safety and efficacy of experimental treatments in clinical trials. Personalized medicine: Pain biomarkers may, in a future, contribute to treatments, tailored to an individual's unique genetic and biological disposition. Reducing opioid misuse: By using biomarkers to assess pain and treatment responses, healthcare providers can make more informed decisions about opioid prescriptions, potentially reducing the overuse and abuse of these medications. |
| format | Online |
| id | doab-20.500.12854ir-132445 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2024 |
| publishDateRange | 2024 |
| publishDateSort | 2024 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1324452024-03-31T13:08:13Z 10th Anniversary of Biomedicines—Biomarkers in Pain Eriksson, Mats B. Larsson, Anders O. analgesia biomarker CSF cytokine inflammation neuropathy neurotransmitter pain QoL sensitization sensory thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology Pain biomarkers are biological indicators or measurable characteristics that can provide information about the presence, severity, or underlying mechanisms of pain. They are valuable for several reasons: Diagnosis and differential diagnosis: Biomarkers can help in the diagnosis of various pain conditions and differentiate between different types of pain, such as neuropathic, inflammatory, or nociceptive pain. This can lead to more accurate and timely diagnoses, which in turn can improve patient care. Monitoring treatment efficacy: Pain biomarkers can be used to track how well treatments are working for individuals suffering from chronic pain conditions. This allows healthcare providers to make informed decisions about adjusting treatment plans, optimizing pain management, and avoiding unnecessary or ineffective interventions. Drug development and testing: Biomarkers play a crucial role in the development of new pain medications and therapies. They can help researchers identify potential drug targets, screen compounds for their pain-relieving properties, and assess the safety and efficacy of experimental treatments in clinical trials. Personalized medicine: Pain biomarkers may, in a future, contribute to treatments, tailored to an individual's unique genetic and biological disposition. Reducing opioid misuse: By using biomarkers to assess pain and treatment responses, healthcare providers can make more informed decisions about opioid prescriptions, potentially reducing the overuse and abuse of these medications. 2024-01-08T14:53:03Z 2024-01-08T14:53:03Z 2023 book ONIX_20240108_9783036597928_104 9783036597928 9783036597935 https://directory.doabooks.org/handle/20.500.12854/132445 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/pdfview/book/8483 https://mdpi.com/books/pdfview/book/8483 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-9793-5 10.3390/books978-3-0365-9793-5 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036597928 9783036597935 160 Basel open access |
| spellingShingle | analgesia biomarker CSF cytokine inflammation neuropathy neurotransmitter pain QoL sensitization sensory thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology 10th Anniversary of Biomedicines—Biomarkers in Pain |
| title | 10th Anniversary of Biomedicines—Biomarkers in Pain |
| title_full | 10th Anniversary of Biomedicines—Biomarkers in Pain |
| title_fullStr | 10th Anniversary of Biomedicines—Biomarkers in Pain |
| title_full_unstemmed | 10th Anniversary of Biomedicines—Biomarkers in Pain |
| title_short | 10th Anniversary of Biomedicines—Biomarkers in Pain |
| title_sort | 10th anniversary of biomedicines biomarkers in pain |
| topic | analgesia biomarker CSF cytokine inflammation neuropathy neurotransmitter pain QoL sensitization sensory thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology |
| topic_facet | analgesia biomarker CSF cytokine inflammation neuropathy neurotransmitter pain QoL sensitization sensory thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology |
| url | ONIX_20240108_9783036597928_104 |